Press Releases

Read our latest announcements

Filter by year:

2011-09-23
Modus Therapeutics initiates a Phase I/II study with Sevuparin for the treatment of severe malaria

Modus Therapeutics today announced that the first patient has received a dose of Sevuparin in a Phase I/II study.

View Press Release